Our revolutionary PGTai technology

Our standard, state-of-the-art PGT-A test

Our revolutionary PGTai technology

Our standard, state-of-the-art PGT-A test

The IVF journey can be challenging, our genetic testing technology makes things easier.

What is PGT-A testing?

PGT-A, or preimplantation genetic testing for aneuploidies, is a genetic test performed on embryos produced through IVF. PGT-A gives information about embryos’ genetic health to help your care team select the best embryo for transfer and improve your chance of achieving a successful pregnancy. PGT-A was formerly known as PGS, preimplantation genetic screening.

How it works

PGT-A works by looking at the amount of genetic material within IVF embryos. This genetic material is housed within structures called chromosomes. Chromosomes are very important for healthy growth and development.

Embryos with the incorrect number of chromosomes (also called aneuploid embryos) typically do not result in a successful pregnancy or may lead to the birth of a child with a genetic condition. Embryos with the correct number of chromosomes (also called euploid embryos) have a better chance of leading to a successful pregnancy. PGT-A identifies embryos with the correct number of chromosomes, so your care team can select the embryo with the best chance of leading to IVF success.

Learn How the PGTai Platform Can Improve Your Chance of IVF Success

Who is PGT-A for?

PGT-A is appropriate for the vast majority of people undergoing IVF.

All women are at risk of producing chromosomally abnormal embryos. As a woman ages, the potential for chromosomally abnormal embryos significantly increases, regardless of the number of embryos produced.

PGT-A can help women of all ages increase their chances of a successful pregnancy.

Benefits of PGT-A

  • Higher chance of pregnancy
  • Reduced risk of miscarriage
  • More confidence in transferring a single embryo, avoiding health risks associated with twin or triplet pregnancies
  • Reduced number of IVF cycles needed to achieve pregnancy, potentially reducing the time to pregnancy and the costs of extra cycles

In 2018, we launched a first-of-its-kind PGT-A test using artificial intelligence